Avalyn shares in silico AP01 lung distribution modeling
Avalyn presented data at ERS Congress 2026 on AP01 lung distribution and a patient-centered pulmonary fibrosis trial design. In silico modeling predicted robust AP01 distribution in healthy and fibrotic lungs, including severe disease.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.